• Compared to human experts, artificial intelligence (AI)-based tests may be comparably accurate at detecting the exudative (or wet) form of age-related macular degeneration (eAMD). • There were no ...
Led by Scale Venture Partners, the $45M investment—the largest Series B in AI Evaluation and Observability to date —follows 834% revenue growth in 2024 and expansion into the Fortune 50 ...